Back to Search
Start Over
MicroRNA-23b downregulates peroxiredoxin III in human prostate cancer.
- Source :
-
FEBS letters [FEBS Lett] 2012 Jul 30; Vol. 586 (16), pp. 2451-8. Date of Electronic Publication: 2012 Jun 16. - Publication Year :
- 2012
-
Abstract
- To investigate the mechanism by which peroxiredoxin III (PRDX3) is altered in human prostate cancer (PCa), we used microRNA (miRNA) target prediction program and miRNA microarray to predict and identify miR-23b as a candidate miRNA that targets PRDX3. We showed that miR-23b suppresses PRDX3 protein expression in human DU145 cells under normal and hypoxic conditions. Additionally, the clinical significance of miR-23b and PRDX3 expression in PCa patients was also confirmed. In conclusion, our data suggest that the effects of PRDX3 in PCa progression may be caused by the regulation function of miR-23b, and consequently, miR-23b may be involved in the response of PCa cells to hypoxia stress.<br /> (Crown Copyright © 2012. Published by Elsevier B.V. All rights reserved.)
- Subjects :
- Aged
Aged, 80 and over
Base Sequence
Cell Line, Tumor
Disease Progression
Disease-Free Survival
Gene Expression Profiling
Humans
Hypoxia
Male
MicroRNAs metabolism
Middle Aged
Molecular Sequence Data
Oligonucleotide Array Sequence Analysis
Down-Regulation
Gene Expression Regulation, Neoplastic
MicroRNAs physiology
Peroxiredoxin III biosynthesis
Prostatic Neoplasms genetics
Prostatic Neoplasms metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1873-3468
- Volume :
- 586
- Issue :
- 16
- Database :
- MEDLINE
- Journal :
- FEBS letters
- Publication Type :
- Academic Journal
- Accession number :
- 22710126
- Full Text :
- https://doi.org/10.1016/j.febslet.2012.06.003